Compare Estee Lauder Companies Inc (EL) vs Revvity Inc (RVTY) Price & Performance

Estée Lauder (EL) trades at $98.05, up 3.81% today, with a neutral technical signal and bullish moving averages. The stock has beaten earnings estimates for three consecutive quarters, though it reported a net loss of $1.13 billion in 2025. Analyst consensus is a Buy with a $103.00 price target, and recent news highlights strategic partnerships in AI and leadership changes.

The outlook is mixed: strong gross margins and recent earnings beats support upside, but high valuation ratios and negative net income pose risks. Investor sentiment is cautiously optimistic, driven by digital initiatives and brand strategy, yet competitive pressures and macroeconomic headwinds remain key concerns for sustained growth.

Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.

The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.